{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T19:35:32Z","timestamp":1717616132014},"reference-count":33,"publisher":"Impact Journals, LLC","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,9,15]]},"DOI":"10.18632\/aging.205002","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T15:47:28Z","timestamp":1694274448000},"page":"8833-8850","source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive analysis of ICD-related lncRNAs in predicting risk stratification, clinical prognosis and immune response for breast cancer"],"prefix":"10.18632","volume":"15","author":[{"given":"Yuli","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, The 960th Hospital of the Chinese People\u2019s Liberation Army, Jinan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, The 960th Hospital of the Chinese People\u2019s Liberation Army, Jinan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2023,9,9]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.","volume":"7","author":"Bray","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1038\/527S101a","article-title":"Breast cancer.","volume":"52","author":"Woolston","year":"2015","journal-title":"Nature"},{"key":"3","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm1469","article-title":"Tumor metastasis: mechanistic insights and clinical challenges.","volume":"1","author":"Steeg","year":"2006","journal-title":"Nat Med"},{"key":"4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1158\/2159-8290.CD-19-0966","article-title":"Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer.","volume":"1","author":"Brufksy","year":"2020","journal-title":"Cancer Discov"},{"key":"5","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.","volume":"38","author":"Inoue","year":"2019","journal-title":"N Engl J Med"},{"key":"6","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.","volume":"37","author":"Chui","year":"2018","journal-title":"N Engl J Med"},{"key":"7","doi-asserted-by":"publisher","first-page":"e000337","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.","volume":"8","author":"Formenti","year":"2020","journal-title":"J Immunother Cancer"},{"key":"8","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1038\/s41467-020-18745-6","article-title":"Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death.","volume":"1","author":"Chen","year":"2020","journal-title":"Nat Commun"},{"key":"9","doi-asserted-by":"publisher","first-page":"e001926","DOI":"10.1136\/jitc-2020-001926","article-title":"Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future.","volume":"9","author":"Krysko","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10","doi-asserted-by":"publisher","first-page":"870914","DOI":"10.3389\/fonc.2022.870914","article-title":"Immunogenic Cell Death-Relevant Damage-Associated Molecular Patterns and Sensing Receptors in Triple-Negative Breast Cancer Molecular Subtypes and Implications for Immunotherapy.","volume":"1","author":"Lin","year":"2022","journal-title":"Front Oncol"},{"key":"11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13543784.2019.1552255","article-title":"Atezolizumab for the treatment of triple-negative breast cancer.","volume":"2","author":"Schmidt","year":"2019","journal-title":"Expert Opin Investig Drugs"},{"key":"12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.6004\/jnccn.2020.7554","article-title":"Role of Immunotherapy in Triple-Negative Breast Cancer.","volume":"1","author":"Tolaney","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"13","doi-asserted-by":"publisher","first-page":"1830524","DOI":"10.1080\/2162402X.2020.1830524","article-title":"Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade.","volume":"9","author":"Formenti","year":"2020","journal-title":"Oncoimmunology"},{"key":"14","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/s41591-019-0432-4","article-title":"Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.","volume":"2","author":"Lalezari","year":"2019","journal-title":"Nat Med"},{"key":"15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jconrel.2021.12.002","article-title":"Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer.","volume":"34","author":"Zhong","year":"2022","journal-title":"J Control Release"},{"key":"16","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1172\/JCI127471","article-title":"cGAS\/STING axis mediates a topoisomerase II inhibitor-induced tumor immunogenicity.","volume":"12","author":"Chen","year":"2019","journal-title":"J Clin Invest"},{"key":"17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.canlet.2020.09.011","article-title":"CDK12\/13 inhibition induces immunogenic cell death and enhances anti-PD-1 anticancer activity in breast cancer.","volume":"49","author":"Tan","year":"2020","journal-title":"Cancer Lett"},{"key":"18","doi-asserted-by":"publisher","first-page":"843077","DOI":"10.3389\/fimmu.2022.843077","article-title":"Molecular Characteristics, Clinical Significance, and Cancer Immune Interactions of Angiogenesis-Associated Genes in Gastric Cancer.","volume":"1","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/1878-0261.12413","article-title":"Long noncoding RNAs as regulators of cancer immunity.","volume":"1","author":"Lo Nigro","year":"2019","journal-title":"Mol Oncol"},{"key":"20","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.2147\/CMAR.S158712","article-title":"A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma.","volume":"1","author":"Cang","year":"2018","journal-title":"Cancer Manag Res"},{"key":"21","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.3390\/ijerph19052989","article-title":"Prevalence and Numbers of Diabetes Patients with Elevated BMI in China: Evidence from a Nationally Representative Cross-Sectional Study.","volume":"1","author":"Li","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"22","doi-asserted-by":"publisher","first-page":"7099930","DOI":"10.1155\/2022\/7099930","article-title":"Necroptosis-Associated lncRNA Prognostic Model and Clustering Analysis: Prognosis Prediction and Tumor-Infiltrating Lymphocytes in Breast Cancer.","volume":"202","author":"Cai","year":"2022","journal-title":"J Oncol"},{"key":"23","doi-asserted-by":"publisher","first-page":"e24384","DOI":"10.1002\/jcla.24384","article-title":"A novel prognostic model associated with the overall survival in patients with breast cancer based on lipid metabolism-related long noncoding RNAs.","volume":"3","author":"Jiang","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"24","doi-asserted-by":"publisher","first-page":"658736","DOI":"10.3389\/fgene.2021.658736","article-title":"A Prognostic Model Based on the Immune-Related lncRNAs in Colorectal Cancer.","volume":"1","author":"Huo","year":"2021","journal-title":"Front Genet"},{"key":"25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.actbio.2022.08.074","article-title":"Role of stiffness and physico-chemical properties of tumour microenvironment on breast cancer cell stemness.","volume":"15","author":"Tirella","year":"2022","journal-title":"Acta Biomater"},{"key":"26","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1200\/JCO.2013.55.0491","article-title":"Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.","volume":"3","author":"Davidson","year":"2014","journal-title":"J Clin Oncol"},{"key":"27","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/annonc\/mdu112","article-title":"Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial.","volume":"2","author":"Denkert","year":"2014","journal-title":"Ann Oncol"},{"key":"28","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1200\/JCO.2011.41.0902","article-title":"Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98.","volume":"3","author":"Di Leo","year":"2013","journal-title":"J Clin Oncol"},{"key":"29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10549-016-3743-x","article-title":"Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.","volume":"15","author":"Iqbal","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"30","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41568-020-0283-9","article-title":"A new dawn for eosinophils in the tumour microenvironment.","volume":"2","author":"Munitz","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41590-019-0321-5","article-title":"Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth.","volume":"2","author":"Schartner","year":"2019","journal-title":"Nat Immunol"},{"key":"32","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/ni.3159","article-title":"Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells.","volume":"1","author":"H\u00e4mmerling","year":"2015","journal-title":"Nat Immunol"},{"key":"33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2217\/imt-2021-0149","article-title":"Peripheral blood eosinophil count is associated with response to chemoimmunotherapy in metastatic triple-negative breast cancer.","volume":"1","author":"Al-Tweigeri","year":"2022","journal-title":"Immunotherapy"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T19:50:10Z","timestamp":1695239410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,9]]},"references-count":33,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2023,9,15]]}},"alternative-id":["205002","37695742"],"URL":"https:\/\/doi.org\/10.18632\/aging.205002","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,9]]}}}